stocksnewsfeed.com
Karyopharm Announces XPOVIO™ (Selinexor) Presentations at the 17th International Myeloma Workshop on Stocks News Feed
NEWTON, Mass., Sept. 13, 2019 (GLOBE NEWSWIRE) — Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an oncology-focused pharmaceutical company, today announced that five abstracts highlighting clinical data for XPOVIO™ (selinexor) will be presented at the 17th International Myeloma Workshop (IMW) taking place September 12-15,... Read moreKaryopharm Announces XPOVIO™ (Selinexor) Presentations at the 17th International Myeloma Workshop